Generics & Modified Generics

Taking advantage of AmProtein's IP positions and production platform, we have developed production cell lines, manufacture process, CMC data and IND application of the following generics and modified generics:

• Enbrel
• Erbitux
• Campath
• Kineret (Fc-fused)
• HBsAg
• EPO
• EPO-HyperG
• FSH
• LH

AmProtein intends to sell these production cell lines, manufacture processes, CMC data and IND applications. We also provide other generic or modified generic development services such as Fc-fused leptin, INF-HyperG, GCSF-HyperG, VEGF-Trap-Fc (developing countries only), BNP-HyperG, HSA, GH-HyperG, tPA-HyperG, IGF-HyperG, BNP2, BNP7, Factor VII, Factor VIII, anti-CD20, anti-IgE and HER2 upon customer request. Our goal is to develop affordable competitive and affordable generic drugs.

For more information about AmProtein's Generic & Modified Generic Proteins, partnerships, and other opportunities, please contact us.

Human & Animal Vaccine Process Development

Taking advantage of AmProtein's high-density cell culture perfusion system we have developed MDCK, VERO, Chicken and Fish cell process. These processes are for sale together with the perfusion system to interested vaccine manufacturers.

AmProtein also welcomes collaborations to work on newly discovered vaccines and push them towards commercialization or grant applications towards final commercialization.